BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15505593)

  • 21. Effects of weight loss on nonalcoholic fatty liver disease.
    Rafiq N; Younossi ZM
    Semin Liver Dis; 2008 Nov; 28(4):427-33. PubMed ID: 18956298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis.
    Fierbinteanu-Braticevici C; Dina I; Petrisor A; Tribus L; Negreanu L; Carstoiu C
    World J Gastroenterol; 2010 Oct; 16(38):4784-91. PubMed ID: 20939106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinicopathologic spectrum and management of nonalcoholic fatty liver disease.
    Contos MJ; Sanyal AJ
    Adv Anat Pathol; 2002 Jan; 9(1):37-51. PubMed ID: 11756758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnosis and therapy in NASH].
    Tokushige K
    Rinsho Byori; 2009 Sep; 57(9):848-53. PubMed ID: 19860210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatty liver and nonalcoholic steatohepatitis.
    Neuschwander-Tetri BA
    Clin Cornerstone; 2001; 3(6):47-57. PubMed ID: 11501194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonalcoholic steatohepatitis.
    Kumar KS; Malet PF
    Mayo Clin Proc; 2000 Jul; 75(7):733-9. PubMed ID: 10907390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonalcoholic Fatty liver disease and obesity.
    Saadeh S
    Nutr Clin Pract; 2007 Feb; 22(1):1-10. PubMed ID: 17242448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.
    Loria P; Marchesini G; Nascimbeni F; Ballestri S; Maurantonio M; Carubbi F; Ratziu V; Lonardo A
    Atherosclerosis; 2014 Jan; 232(1):99-109. PubMed ID: 24401223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current pharmacological treatment of nonalcoholic fatty liver.
    Portincasa P; Grattagliano I; Palmieri VO; Palasciano G
    Curr Med Chem; 2006; 13(24):2889-900. PubMed ID: 17073635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
    Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
    World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonalcoholic fatty liver disease.
    Jonas MM
    Adolesc Med Clin; 2004 Feb; 15(1):159-73, xi. PubMed ID: 15272263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis and pathways: nonalcoholic fatty liver disease & alcoholic liver disease.
    Robinson KE; Shah VH
    Transl Gastroenterol Hepatol; 2020; 5():49. PubMed ID: 33073044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic steatohepatitis and the metabolic syndrome.
    Jiang J; Torok N
    Metab Syndr Relat Disord; 2008 Mar; 6(1):1-7. PubMed ID: 18370830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic Syndrome: Nonalcoholic Fatty Liver Disease.
    Williams T
    FP Essent; 2015 Aug; 435():24-9. PubMed ID: 26280342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonalcoholic steatohepatitis in children.
    Roberts EA
    Curr Gastroenterol Rep; 2003 Jun; 5(3):253-9. PubMed ID: 12734049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes mellitus, obesity, and hepatic steatosis.
    Youssef W; McCullough AJ
    Semin Gastrointest Dis; 2002 Jan; 13(1):17-30. PubMed ID: 11944630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiology of non-alcoholic steatohepatitis and basis for treatment.
    Pinzani M
    Dig Dis; 2011; 29(2):243-8. PubMed ID: 21734391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonalcoholic Fatty liver disease.
    Jorgensen RA
    Gastroenterol Nurs; 2003; 26(4):150-4; quiz 154-5. PubMed ID: 12920429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.